News & Media

Take a closer look at what we’re doing across Teva worldwide

Press releases

Teva Announces Launch of a Generic Version of NuvaRing® (etonogestrel and ethinyl estradiol) Vaginal...

Teva Announces Launch of a Generic Version of NuvaRing® (etonogestrel and ethinyl estradiol) Vaginal Ring

Teva Sets Ambitious Long-Term Environmental Goals As Part of Renewed ESG Strategy

Teva Sets Ambitious Long-Term Environmental Goals As Part of Renewed ESG Strategy

Teva to Host Conference Call to Discuss Fourth Quarter 2020 Financial Results and 2021 Financial Gui...

Teva to Host Conference Call to Discuss Fourth Quarter 2020 Financial Results and 2021 Financial Guidance

Teva to Present at the 39th Annual J.P. Morgan Healthcare Conference

Teva to Present at the 39th Annual J.P. Morgan Healthcare Conference

Teva and MedinCell Announce Positive Results for Registration Trial of Investigational Extended-Rele...

Teva and MedinCell Announce Positive Results for Registration Trial of Investigational Extended-Release S

Teva Reports Third Quarter 2020 Financial Results

Teva Reports Third Quarter 2020 Financial Results

Teva, Amazon Web Services and Onica Announce Collaboration to Support Teva’s Digihaler® Portfolio

Teva, Amazon Web Services and Onica Announce Collaboration to Support Teva’s Digihaler® Portfolio

Teva Announces New Analysis of Consistency in Migraine Days Over the Course of a Dosing Regimen for ...

Teva Announces New Analysis of Consistency in Migraine Days Over the Course of a Dosing Regimen for AJOVY

Teva Launches First Generic Versions of HIV-1 Treatments TRUVADA® (emtricitabine 200 mg/tenofovir di...

Teva Launches First Generic Versions of HIV-1 Treatments TRUVADA® (emtricitabine 200 mg/tenofovir disopro

Teva to Host Conference Call to Discuss Third Quarter 2020 Financial Results at 8 a.m. ET on Novembe...

Teva to Host Conference Call to Discuss Third Quarter 2020 Financial Results at 8 a.m. ET on November 5,
See all press releases
Previous
Next

Top Stories

Read the latest Teva news

Teva sets ambitious long-term environmental goals

Teva sets ambitious long-term environmental goals

‘It has made a real difference’: Increasing access to medicines in Haiti

‘It has made a real difference’: Increasing access to medicines in Haiti

‘Biosimilars are advancing more treatment options for patients’

‘Biosimilars are advancing more treatment options for patients’

‘I’ve seen the impact that asthma and COPD can have.’

‘I’ve seen the impact that asthma and COPD can have.’

“Half the world’s people lack access to medicines.”

“Half the world’s people lack access to medicines.”

Antibiotics Aren’t Always the Solution

Antibiotics Aren’t Always the Solution

Our Commitment to HIV

Our Commitment to HIV

Meet the Expert – Mike Smith

Meet the Expert – Mike Smith

GlobalDiversityMo

GlobalDiversityMo

Hispanic Heritage Month

Hispanic Heritage Month
View all stories

Media Resources

Intended for use by media professionals; may be downloaded for non-commercial use 

Media Inquiries

Contact our corporate communications.

Learn more Media Inquiries

Media Kit

Files and resources for media use only

Download Teva Media Kit Media Kit

Financial Reports

View Teva financial news on our global website.

Learn more Financial Reports

Connect with us

Teva Social Media Guidelines.

Learn more Connect with us